FINASTEN 1mg 30tabs.

FINASTEN 1mg 30tabs. is a hair and scalp treatment from FINASTEN, listed for registered Australian clinics in our Hair treatment range. Pack: 1mg 30tabs. Priced in AUD (A$39.00). Sydney dispatch, nationwide. Not a public treatment clinic.

About FINASTEN 1mg 30tabs.

Finasten Tablet is:

1. It is a drug that treats the direct cause of male pattern baldness. Finasten Tablet treats the cause of hair loss by inhibiting the action of 5α-reductase that converts testosterone into DHT, thereby reducing the concentration of DHT, the main cause of male patter hair loss.
2. It brings high patient satisfaction with excellent effect. Finasten Tablet effectively treats hair loss by increasing the number and weight of hair and growing it into healthy hair in a short time.
3. It is a safe formulation with very low incidence of side effects. Finasten Tablet has a side effect rate similar to that of placebo, which also disappears when you stop taking the drug.

Drug Information

Ingredients
Finasteride (USP) 1mg in 1 tablet (150mg)
Additives: Opadry Pink 85G44100, Celllactose 80, Sodium Lauryl Sulfate, Sodium Starch Glycolate, Magnesium Stearate Additive.
Ingredients for caution: Cellactose 80

Identification
Yellowish-brown, biconvex, octagonal, and film-coated tablet

Efficacy / Effect
Treatment of male pattern hair loss (androgenetic alopecia) in adult males (ages 18 to 41)

Dosage
In general, finasteride 1 mg is orally administered once a day and regardless of before or after a meal.
There is no evidence that increasing the dose increases efficacy.
In general, it needs to be taken for more than 3 months to see the therapeutic effect, and it is recommended to take it continuously to maintain the therapeutic effect.
The duration and effectiveness of treatment should be continuously evaluated.
In case of discontinuation, the therapeutic effect will disappear within 12 months.

Precautions for use
Warning
1) This drug must not be administered to pediatric patients or women (see the section Administration for Children and section Administration for Pregnant Women).
2) If pregnant or possibly pregnant women touch broken pieces of the drug, there is a possibility that this medicine may be absorbed through the skin and pose a risk to the male fetus, so women must not
touch broken pieces of this drug. Since the surface of this drug is coated, the active ingredient does not contact the skin when the tablet is handled normally in an unbroken state (refer to the section Administration for Pregnant Women).
Please refer to the product documentation for more information.

Packing unit
30 tablets (10 tablets/PTP*3)

Storage/Shelf life
Store at 15-30℃ in an airtight container avoiding moisture, 36 months from the date of manufacture

Stop Hair Loss! Start Hair Growth!
Finasten Tablet is a solution for your hair loss treatment.

A treatment for hair loss

1. It is a drug that treats the direct cause of male pattern baldness.
2. It brings high patient satisfaction with excellent effect.
3. It is a safe formulation with very low incidence of side effects.

FINASTEN 1mg 30tabs. — key details for ordering

• Product: FINASTEN 1mg 30tabs.
• Brand: FINASTEN
• Category: Hair treatment
• Pack format: 1mg 30tabs
• Price: A$39.00 AUD, including GST where applicable
• Dispatch: Sydney, Australia-wide

Using FINASTEN 1mg 30tabs. in clinic practice

Hair and scalp products are typically used as a course of treatments. Check the vial or ampoule format and concentration on this page against your protocol, and order enough units for the planned treatment series.

Ordering FINASTEN 1mg 30tabs. and related products

Compare FINASTEN 1mg 30tabs. with Dermaheal HL mesotherapy, Eldermafill Hair Forest (5ml x 4vials), HAIR BLOOM Hair Filler, or browse the full Hair treatment catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for FINASTEN 1mg 30tabs. is covered in the reference article on Hair loss, and Australian practitioners should confirm regulatory positionings with the TGA before use.